UK pharmaceutical manufacturer AstraZeneca has agreed a partnership with Russia's Gamelaya institute to work on a combined Covid-19 vaccine.
Both have produced their own vaccines, with Gamelaya reporting efficacy of more than 90%, and AstraZeneca reporting around 70%.
Now AstraZeneca will conduct a clinical trial to test a combination of both vaccines.
Stuart Smith has more from Moscow.
Both have produced their own vaccines, with Gamelaya reporting efficacy of more than 90%, and AstraZeneca reporting around 70%.
Now AstraZeneca will conduct a clinical trial to test a combination of both vaccines.
Stuart Smith has more from Moscow.
IN: "In a press..."
OUT: SOC
DURATION: 37 Seconds